Transformation Capital leads $21M investment in Solstice, enabling pharma brands to slash medical, legal, and regulatory marketing review cycles from weeks to less than 48…
Transformation Capital leads $21M investment in Solstice, enabling pharma brands to slash medical, legal, and regulatory marketing review cycles from weeks to less than 48…